Dr. Kim Ann Mink Ph.D., is Independent Director of the Company. Dr. Mink was President and Chief Executive Officer of Innophos Holdings, Inc., a leading international producer of performance-critical and nutritional functional ingredients, with applications in food, health, nutrition and industrial specialties markets, from December 2015, a director of Innophos from January 2016, and Chairman of the Board from February 2017, until completion of One Rock Capital Partners’s acquisition of Innophos in February 2020. Dr. Mink previously served as Business President of Elastomers, Electrical and Telecommunications at The Dow Chemical Company from September 2012 to December 2015. Dr. Mink joined Dow in April 2009 as Global General Manager, Performance Materials and President and Chief Executive Officer of ANGUS Chemical Co. (then a subsidiary of Dow). Prior to joining Dow, she had previously served for more than 20 years at the Rohm and Haas Company (which was acquired by Dow) where she held roles of increasing responsibility, including corporate vice president and general manager for the Ion Exchange Resins business. Dr. Mink is also a member of the Board of Directors of PolyOne Corp.
As the Independent Director of Eastman Chemical Co, the total compensation of Kim Mink at Eastman Chemical Co is $276,565. There are 15 executives at Eastman Chemical Co getting paid more, with Mark Costa having the highest compensation of $14,556,100.
Kim Mink is 60, he's been the Independent Director of Eastman Chemical Co since 2018. There are 6 older and 17 younger executives at Eastman Chemical Co. The oldest executive at Eastman Chemical Co is David Raisbeck, 70, who is the Independent Director.
Over the last 21 years, insiders at Eastman Chemical Co have traded over $96,127,977 worth of Eastman Chemical Co stock and bought 14,500 units worth $1,058,425 . The most active insiders traders include Michael P Connors, Donald W Slager, and Howard L Lance. On average, Eastman Chemical Co executives and independent directors trade stock every 28 days with the average trade being worth of $1,672,313. The most recent stock trade was executed by Adrian James Holt on 3 June 2024, trading 1,975 units of EMN stock currently worth $153,556.
sculpture, furniture design, membrane tension structures, engineering consultant. design bias includes tension, friction, gravity and levity.
Eastman Chemical Co executives and other stock owners filed with the SEC include: